IFA

How does an adjuvant work?

A purified protein injected on its own is often ignored. The immune system responds strongly to signals of danger, and a clean protein carries none. An immune adjuvant supplies that missing alarm. This one works in two ways at once: the water droplets holding the antigen are suspended in oil, forming a depot that leaks its contents over weeks rather than minutes, and the oil irritates the surrounding tissue enough to recruit the cells that present antigen to lymphocytes. The result is a stronger and longer lasting response than the antigen alone would produce.

How does it differ from the complete version?

Where is it used?

Its established home is the laboratory, where it is standard for raising antibodies in animals, usually with the complete form for the first injection and this milder version for boosters. In people it has been used in experimental cancer vaccines, in which fragments of a tumor protein are emulsified with it and injected to provoke an immune response against cells carrying that protein. A refined pharmaceutical grade version is the one used in those trials. Results have been mixed, and evidence emerged that the depot can trap the very immune cells it recruits at the injection site rather than sending them to the tumor, which prompted a rethink of the approach.

Why is the abbreviation confusing?

The same three letters commonly mean immunofluorescence assay, an entirely different thing: a laboratory test in which antibodies tagged with a fluorescent dye are used to detect a target in a sample, viewed under a microscope that makes the dye glow. Which meaning applies is usually clear from context, since one appears in vaccine and immunization records and the other in laboratory results.